NCT02289924View on ClinicalTrials.gov

Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy

CompletedOBSERVATIONAL
Enrollment

912

Participants

Timeline

Start Date

January 9, 2015

Primary Completion Date

March 28, 2019

Study Completion Date

July 8, 2019

Conditions
Wet Macular Degeneration
Interventions
DRUG

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Administration by intravitreal injection

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY